Doximity Inc
NYSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Doximity Inc
NYSE:DOCS
|
US |
|
C
|
CBRE Group Inc
SWB:RF6
|
US |
|
Boston Beer Company Inc
NYSE:SAM
|
US |
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
TH |
|
Mitsui Chemicals Inc
TSE:4183
|
JP |
|
Northrop Grumman Corp
NYSE:NOC
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
Canadian National Railway Co
TSX:CNR
|
CA |
|
Talanx AG
XETRA:TLX
|
DE |
|
Tesco PLC
LSE:TSCO
|
UK |
|
Nippon Avionics Co Ltd
TSE:6946
|
JP |
|
D
|
Doosan Robotics Inc
KRX:454910
|
KR |
|
Naver Corp
KRX:035420
|
KR |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
Cooper-Standard Holdings Inc
NYSE:CPS
|
US |
|
Snowflake Inc.
NYSE:SNOW
|
US |
|
Kidoz Inc
XTSX:KDOZ
|
CA |
|
Huaneng Lancang River Hydropower Inc
SSE:600025
|
CN |
|
Walmart Inc
NASDAQ:WMT
|
US |
|
S
|
Super Group Ltd
JSE:SPG
|
ZA |
|
Creek & River Co Ltd
TSE:4763
|
JP |
|
Novartis AG
SIX:NOVN
|
CH |
|
H
|
Hacksaw AB
STO:HACK
|
SE |
|
Nexstar Media Group Inc
NASDAQ:NXST
|
US |
Doximity Inc
Doximity is a digital network for medical professionals in the United States, especially doctors, nurses, and other clinicians. Its main products are a professional social network, messaging and telehealth tools, electronic faxing and workflow apps, and a news and reference feed tailored to healthcare workers. The company’s platform helps clinicians communicate with one another, manage patient-related tasks, and stay connected to medical information in one place. Doximity makes money mainly by selling access to its audience and workflow tools. Pharmaceutical companies, health systems, and other healthcare businesses pay to reach verified clinicians with targeted advertising, sponsorships, and recruiting or communications products. In effect, Doximity sits between the healthcare workforce and the companies that want to market to, hire, or communicate with that workforce. What makes the business unusual is that it is not a hospital system, insurer, or drug maker; it is a professional utility built around trusted identity and daily use by clinicians. That gives it a specialized role in healthcare communications and physician engagement. Its value comes from being a closed, credentialed network where the users are medical professionals and the customers are organizations that need direct access to them.
Doximity is a digital network for medical professionals in the United States, especially doctors, nurses, and other clinicians. Its main products are a professional social network, messaging and telehealth tools, electronic faxing and workflow apps, and a news and reference feed tailored to healthcare workers. The company’s platform helps clinicians communicate with one another, manage patient-related tasks, and stay connected to medical information in one place.
Doximity makes money mainly by selling access to its audience and workflow tools. Pharmaceutical companies, health systems, and other healthcare businesses pay to reach verified clinicians with targeted advertising, sponsorships, and recruiting or communications products. In effect, Doximity sits between the healthcare workforce and the companies that want to market to, hire, or communicate with that workforce.
What makes the business unusual is that it is not a hospital system, insurer, or drug maker; it is a professional utility built around trusted identity and daily use by clinicians. That gives it a specialized role in healthcare communications and physician engagement. Its value comes from being a closed, credentialed network where the users are medical professionals and the customers are organizations that need direct access to them.
Beat and cash flow: Doximity finished fiscal Q4 above the high end of guidance, with revenue of $145 million and record quarterly free cash flow of $107 million, its first 9-digit free cash flow quarter.
AI push: Management called fiscal 2027 an "AI investment year," saying it is spending more on compute, R&D and marketing to build and monetize AI Search and Scribe, even if that pressures near-term margins.
Guidance: The company guided fiscal Q1 revenue to $151 million to $152 million and full-year fiscal 2027 revenue to $664 million to $676 million, implying about 4% growth at the midpoint.
Market softness: Pharma marketing demand remains soft, with shorter-duration commitments, limited visibility and more cautious budgets driven by policy uncertainty and macro risk.
AI commercialization: Doximity said it has already signed its first few AI Search deals with top 20 pharma manufacturers, but meaningful revenue contribution is expected later in the fiscal year.
Operating discipline: Even with heavier AI investment, management said it still expects adjusted EBITDA margins in the high 40s or better in fiscal 2027 and continues buying back stock aggressively.
